[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336824-105":59,"doc-detail-336824-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","incidence-rate-and-risk-factors-of-second-primary-neoplasms-among-older-patients-with-hematological-malignancies-insights-from-a-chinese-single-center-experience-19972021","Incidence rate and risk factors of second primary neoplasms among older patients with hematological malignancies: Insights from a Chinese single-center experience (1997–2021)","","Patients with hematological malignancies face an elevated likelihood of developing second primary neoplasms, but the incidence and determinants in older adults remain insufficiently characterized. This retrospective single-center analysis evaluated 163 older patients, estimating cumulative incidence and assessing risk factors with a competing risk model. Results quantified an incidence rate of 15.72 per 1000 person-years and a standardized incidence ratio of 0.81. Prior radiotherapy increased risk, whereas regular natural killer (NK) cell infusion was associated with reduced risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/incidence-rate-and-risk-factors-of-second-primary-neoplasms-among-older-patients-with-hematological-malignancies-insights-from-a-chinese-single-center-experience-19972021/336824/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/incidence-rate-and-risk-factors-of-second-primary-neoplasms-among-older-patients-with-hematological-malignancies-insights-from-a-chinese-single-center-experience-19972021/336824.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s goal regarding second primary neoplasms in older patients?","Question",{"text":112,"@type":113},"To assess incidence, identify risk factors, and evaluate survival impact among older patients with hematological malignancies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was incidence estimated and risk factors analyzed?",{"text":117,"@type":113},"Cumulative incidence rates were calculated, and risk factors were evaluated using a competing risk model based on retrospective single-center data.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were associated with increased versus decreased risk?",{"text":121,"@type":113},"History of radiotherapy was linked to a significantly higher risk, while regular natural killer (NK) cell infusion was associated with reduced risk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336824,1790600755,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Cancer Pathogenesis and Therapy 2 (2024) 285–291  \nContents lists available at ScienceDirect  \nCancer Pathogenesis and Therapy  \njournal [homepage:](homepage: www.journals.elsevier.com/cancer-pathogenesis-and-therapy)[ www.journals.elsevier.com/cancer-pathogenesis-and-therapy](homepage: www.journals.elsevier.com/cancer-pathogenesis-and-therapy)  \nResearch article  \nIncidence rate and risk factors of second primary neoplasms among older patients with hematological malignancies: Insights from a Chinese single-center experience (1997–2021)☆  \nYadi Zhong a, Bing Zhai a, Jing Zengb, Bo Yang a, Bo Guo a, *, Xuechun Lu a, **  \na Department of Hematology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China b Department of Endocrinology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China  \nH I G H L I G H T S  \n\n| 􀀁 Older patients with hematological malignancies should be informed of the risk of developing secondary primary neoplasms.\u003Cbr>􀀁 In older patients with hematological malignancies, the standardized incidence ratio (SIR) of second primary neoplasms was 0.81 in a Chinese center.\u003Cbr>􀀁 Radiation therapy is a risk factor, whereas the regular infusion of natural killer (NK) cells protects against secondary primary neoplasms. |\n| --- |\n| A R T I C L E I N F O |\n| Managing Editor: Peng Lyu |\n\nKeywords:  \nHematological malignancies Second primary neoplasms Older  \nIncidence  \nRisk factors  \nG R A P H I C A L A B S T R A C T  \n\n| |\n| --- |\n| A B S T R A C T |\n\nBackground: Patients with hematological malignancies face an increased risk of developing second primary neoplasms due to various factors, including immune system compromise and chemotherapy-related effects. However, the incidence and associated risk factors in older patients remain poorly understood. This study aimed to assess the incidence, identify risk factors, and evaluate their impact on survival outcomes among older patients with hematological malignancies.  \nMethods: This retrospective single-center study analyzed data from 163 patients, focusing on the occurrence of second primary neoplasms. Cumulative incidence rates were calculated, and risk factor analysis was conducted using a competing risk model.  \n☆ Given his role as Editorial board member, Prof. Xuechun Lu had no involvement in the peer-review of this article and has no access to information regarding its peer-review. Full responsibility for the editorial process for this article was delegated to Managing Editor, Peng Lyu.  \n* Corresponding author: Department of Hematology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China.  \n** Corresponding author: Department of Hematology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China.  \nE-mail addresses: [drguobo@163.com](drguobo@163.com) (B. Guo), [luxuechun@126.com](luxuechun@126.com) (X. Lu).  \n[https://doi.org/10.1016/j.cpt.2024.06.001](https://doi.org/10.1016/j.cpt.2024.06.001)  \nReceived 22 February 2024; Received in revised form 1 June 2024; Accepted 4 June 2024  \n2949-7132/© 2024 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA). This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nY. Zhong et al. Cancer Pathogenesis and Therapy 2 (2024) 285–291  \nResults: Among 124 eligible patients with a total follow-up duration of 572.57 person-years, the incidence rate of second primary neoplasms was 15.72/1000 person-years. The standardized incidence ratio (SIR) was 0.81 (95% conﬁdence interval [CI][0.39–1.4","cbCaidrE9plOCHEt","https://ap.wps.com/l/cbCaidrE9plOCHEt","pdf",950277,"English","# Article Info\n## Highlights\n## Abstract\n# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What was the study’s goal regarding second primary neoplasms in older patients?\",\"answer\":\"To assess incidence, identify risk factors, and evaluate survival impact among older patients with hematological malignancies.\"},{\"question\":\"How was incidence estimated and risk factors analyzed?\",\"answer\":\"Cumulative incidence rates were calculated, and risk factors were evaluated using a competing risk model based on retrospective single-center data.\"},{\"question\":\"Which factors were associated with increased versus decreased risk?\",\"answer\":\"History of radiotherapy was linked to a significantly higher risk, while regular natural killer (NK) cell infusion was associated with reduced risk.\"}]","Incidence rate and risk factors of second primary neoplasms among older patients with hematological malignancies: Insights from a Chinese single-center experience (1997–2021) | PDF",1790016748,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2091d62c94cf6eb9959710755e85780b.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3eac71cccdcf1c98b4151c09b425a3e4.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/654acabed89920876fd064f3a874ddfd.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a538c3dc59c33457388ea44e60543f2.webp",980,1306]